197 related articles for article (PubMed ID: 27430709)
1. Non-inferiority tests for anti-infective drugs using control group quantiles.
Fay MP; Follmann DA
Clin Trials; 2016 Dec; 13(6):632-640. PubMed ID: 27430709
[TBL] [Abstract][Full Text] [Related]
2. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
[TBL] [Abstract][Full Text] [Related]
3. On non-inferiority margin and statistical tests in active control trials.
Chow SC; Shao J
Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
[TBL] [Abstract][Full Text] [Related]
4. Issues on the selection of non-inferiority margin in clinical trials.
Hou Y; Wu XY; Li K
Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
[TBL] [Abstract][Full Text] [Related]
5. The Smooth Away From Expected (SAFE) non-inferiority frontier: theory and implementation with an application to the D3 trial.
Quartagno M; Chan M; Turkova A; Ford D; White IR
Trials; 2023 Aug; 24(1):556. PubMed ID: 37626423
[TBL] [Abstract][Full Text] [Related]
6. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
Weir IR; Trinquart L
Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
[TBL] [Abstract][Full Text] [Related]
7. Design and analysis of non-inferiority mortality trials in oncology.
Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
[TBL] [Abstract][Full Text] [Related]
8. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
Ganju J; Rom D
Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
[TBL] [Abstract][Full Text] [Related]
9. Non-inferiority margins employed in clinical trials in Japan.
Gosho M
J Clin Pharm Ther; 2015 Jun; 40(3):289-98. PubMed ID: 25827098
[TBL] [Abstract][Full Text] [Related]
10. Impact of disinvestment from weekend allied health services across acute medical and surgical wards: 2 stepped-wedge cluster randomised controlled trials.
Haines TP; Bowles KA; Mitchell D; O'Brien L; Markham D; Plumb S; May K; Philip K; Haas R; Sarkies MN; Ghaly M; Shackell M; Chiu T; McPhail S; McDermott F; Skinner EH
PLoS Med; 2017 Oct; 14(10):e1002412. PubMed ID: 29088237
[TBL] [Abstract][Full Text] [Related]
11. Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance.
Parienti JJ; Verdon R; Massari V
BMC Med Res Methodol; 2006 Sep; 6():46. PubMed ID: 16987409
[TBL] [Abstract][Full Text] [Related]
12. When inferiority meets non-inferiority: implications for interim analyses.
Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
[TBL] [Abstract][Full Text] [Related]
13. Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpoint.
Ni S; Yu Q; Zhong Z; Yang M; Zhao Y; Wu J; Bai J; Yu H
J Biopharm Stat; 2023 Jan; 33(1):15-30. PubMed ID: 35791856
[TBL] [Abstract][Full Text] [Related]
14. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Wang YC; Chen G; Chi GY
J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
[TBL] [Abstract][Full Text] [Related]
15. Non-inferiority tests for binary endpoints with variable margins.
Ren Y; Wang C; Shen M; Tsong Y
J Biopharm Stat; 2019; 29(5):822-833. PubMed ID: 31486705
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of non-inferiority and equivalence randomized trials of anti-infective drugs.
Li Y; He Y; Sheng Y; Wang K; Wang J; Huang J; Yang J; Zheng Q
Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1377-89. PubMed ID: 24180484
[TBL] [Abstract][Full Text] [Related]
17. A more efficient three-arm non-inferiority test based on pooled estimators of the homogeneous variance.
Lu H; Jin H; Zeng W
Stat Methods Med Res; 2018 Aug; 27(8):2437-2446. PubMed ID: 27920362
[TBL] [Abstract][Full Text] [Related]
18. Non-inferiority trials in cardiology: what clinicians need to know.
Leung JT; Barnes SL; Lo ST; Leung DY
Heart; 2020 Jan; 106(2):99-104. PubMed ID: 31672779
[TBL] [Abstract][Full Text] [Related]
19. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
20. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
Li Z; Quartagno M; Böhringer S; van Geloven N
Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
